Design, synthesis, characterization and biological evaluation of Benzothiazole-6-carboxylate derivatives by Sushant Sudhir Pande, T. Panneer Selvam, Padmavathi P. Prabhu, C. S. Shastry
 
Research in Pharmacy 1(2) : 6-12, 2011                                                                 ISSN : 2231-539X 
www.researchinpharmacy.com 
 
 
Regular Article 
Design, synthesis, characterization and biological evaluation 
of Benzothiazole-6-carboxylate derivatives 
 
Padmavathi P. Prabhu*a, C. S. Shastryb, Sushant Sudhir Pandea, T. Panneer Selvama 
 
aDepartment of Pharmaceutical chemistry,  Srinivas College of Pharmacy, Valachil,  
Mangalore- 574 143,  Karnataka, India. 
bDepartment of Pharmacology, NGSMIPS, Paneer, Deralakatte, Mangalore. 
Corresponding Author email: padmapprabhu@gmail.com  
 
 
A parent benzothiazole molecule was synthesized by Jacobson synthesis, then it 
is subjected to treatment with various aromatic aldehydes to get the corresponding Schiff 
bases followed by esterification of carboxyl group by using various alcohols. The 
structures of synthesized compounds were confirmed by various spectroscopic methods 
such as IR, NMR and mass spectroscopy. The products were evaluated for their 
antimicrobial activity. Some of the compounds exhibited potent activity when compared 
with the standards.  
 
Key words: Benzothiazole; Schiff base; Esterification; Antimicrobial activity. 
 
 
Benzothiazole nucleus is present in 
various compounds and it is responsible for 
various biological activities. The present 
work mainly focuses on the benzothiazoles 
with potential activities that are now in 
development.  Benzothiazoles are bicyclic 
ring system with multiple applications. 
Amino-benzothiazoles constitute an 
important class of compounds.  In recent 
year heterocyclic compounds analogues 
and derivatives have attracted strong 
interest due to their useful biological and 
pharmacological properties.  Proposed 
work is based upon the development of 
some newer structurally related 
compounds of benzothiazoles and 
evaluation of biological activity. 
Benzothiazoles shows diverse biological 
activities ranging from antiparasitic 
(Alaimo, 1974), anti-inflammatory (Singh, 
1986), antitumor (Schnur, 1991 and  
Hutchinson, 2003),   immunosuppressive 
(Paget, 1969 and Hugershoff, 1901),  anti- 
tubercular activity (Leon, 1951). Such wide 
range of activities motivated us to develop 
newer analogues of the benzothiazole 
expecting better biological activity. 
Synthesis of the basic nucleus is well 
established and the proposed derivatives 
can be synthesized based upon the 
literature available about the reaction 
involved. Although they have been known 
from long ago to be biologically active 
(Caleta, 2004, Bhusari, 2000 and Nargund, 
1998), their varied biological features are 
still of great scientific interest. 
Benzothiazoles show antitumor activity, 
especially the phenyl-substituted 
benzothiazoles (Leong, 2004 and Bradshaw, 
2002). Substituted 6-nitro- and 6-
aminobenzothiazoles (Hutchinson, 2001) 
show antimicrobial activity. In connection 
with our earlier studies on the synthesis 
and biologic properties of substituted 
benzothiazoles (Prabhu, 2011 and Prabhu, 
2010) we now focused our attention on the 
synthesis and biological evaluation of novel 
alkyl-2-(4-(benzylideneamino) phenyl) 
benzo thiazole-6-carboxylate as analogous 
of 2-(4-(benzylideneamino) phenyl) benzo 
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thiazole-6-carboxylic acid. We have given 
below a brief account of various alterations 
conducted on benzothiazole ring and their 
antimicrobial activity. 
 
Material and methods 
Melting points of synthesized compounds 
were determined by melting point 
apparatus and uncorrected. NMR spectra 
were recorded on BRUKER-spectrospin 
400MHz spectrometer in CDCl3, Tetra 
methyl silane (TMS; δ = 0.00 ppm) served 
as internal standards for 1H NMR. The 
corresponding residual non-deuterated 
solvent signal (CDCl3: δ = 77.00 ppm) was 
used as internal standards for 13C NMR. IR 
spectra were measured using a JASCO 
FT/IR-410 spectrometer, and Perkin-Elmer 
FT/IR Spectrum BX, GX. Mass spectra were 
measured with Micromass Q-Tof (ESI-
HRMS). Column chromatography was 
conducted on Silica gel 230-400 mesh 
(Merck) and preparative thin-layer 
chromatography was carried out using 
SILICA GEL GF-254. Spectras were 
obtained from IISC Bangalore. The physical 
data of the derivatives are listed in table I. 
The scheme of synthesis is given in 
schemes 1 and 2. 
 
In scheme 1 parent benzothiazole molecule 
was synthesized by Jacobson method using 
Lawsson’s reagent, the product obtained 
was used for the synthesis of various 
benzothiazole-6-carboxylate derivatives as 
shown in the scheme 2. 
 
Scheme 1: Synthesis of parent benzothiazole molecule 
 
 
Scheme 2: Synthesis of benzothiazole-6-carboxylate derivatives
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Procedure 
Synthesis of N-(4-Carboxy phenyl)-4- nitro 
phenyl benzamide (1a) : To a solution of p-
amino benzoic acid (11.5 g, 62.6 mmol) in 
dichloro methane (100 ml) was added 
pyridine (40 ml) followed by addition of 
mixture of p-nitro benzoyl chloride (8 ml, 
68.9 mmol) in toluene (30 ml). Then, the 
mixture was heated at reflux for 5 hrs., after 
this, toluene was removed under vacuum, 
100 ml water was added then product was 
extracted with dichloromethane (3×100ml) 
and dichloromethane layer was rinsed with 
1M HCl (200 ml) followed by washing with 
20% 100ml aqueous solution of sodium 
carbonate. The organic layer was then dried 
over sodium sulphate (Na2SO4) and 
concentrated to produce benzamide 
derivative 1a as a purple crystalline solid. 
The compound was recrystallised from 
dichloromethane and hexane. Yield = 86 %. 
Synthesis of N-(4-Carboxy phenyl)-4- 
nitrophenyl thio benzamide (2a): To a 
solution compound 1a (1.0 g) in 40 ml dry 
toluene was added lawesson’s reagent (0.6 
molar eq). The mixture was heated under an 
atmosphere of nitrogen at reflux for 2 hrs. 
after which it was concentrated and purified 
by column chromatography to give yellow 
crystals. Yield 85 % 
Synthesis of 6-carboxy-2-(P-nitrophenyl) 
benzothiazole (3a): To the compound 2a 
(0.1g) in 0.5 ml ethanol was added 1.5 M 7 
ml NaOH. The solution was cooled in an 
ice-bath and freshly prepared aqueous 
potassium ferricyanide (2-3 molar 
equivalents) was added. The reaction 
mixture was stirred at room temperature for 
24 hr.; then, the mixture was neutralized 
with 1M HCl and extracted with ethyl 
acetate (3×75ml). The organic layer was 
dried over Na2SO4. Then organic layer was 
removed in vacuum and the residue is 
purified by recrystallisation from ethanol or 
ethyl acetate: hexanes to give white needles. 
Yield 79% 
Synthesis of 6-carboxy-2-(p-aminophenyl) 
benzothiazole (4a): To 6-carboxy-2-(p-
nitrophenyl)-benzothiazole 3a (5g, 25 mmol) 
in 20ml ethanol: 10ml water was added iron 
powder (4.1g, 75 mmol) (325 mesh) and 
ammonium chloride (0.7g, 12.5 mmol).The 
reaction was stirred at 85oC for one hr., 
cooled to room temperature, and filtered 
through celite. The filter cake was then 
washed with 100ml toluene and the filtrate 
and filtrate was washed with water (2 ×100 
ml). The toluene layer was dried over 
MgSO4 or Na2SO4 and concentrated to a 
solid that was triturated with hexane (25 
ml). The solid was separated by filtration. 
Yield = 86% 
General procedure for the synthesis of 
Schiff bases of benzothiazole (5a-5c):  
6-carboxy-2-(P-aminophenyl) benzothiazole 
4a (0.025 moles) was dissolved in 20 ml 
ethanol, followed by drop wise addition of 
substituted aromatic aldehyde (0.030 moles) 
dissolved in 10ml ethanol at room 
temperature. The reaction mixture was 
stirred for 24 hr at room temperature. Then, 
ethanol was evaporated and product was 
recrystallized from ethyl acetate: hexane 
mixture. 
General Procedure for the synthesis of 
corresponding esters of benzothiazoles 
(P5a-P5h): To the corresponding compound 
(5a-5c) (5.58 mmoles) added corresponding 
alcohol (27.9 mmoles). Followed by the 
addition of thionyl chloride (6.69 mmoles). 
Then reaction mixture was refluxed for 5 
hrs. The excess of thionyl chloride and the 
alcohol was removed under reduced 
pressure. The product washed with 
sufficient cold Petroleum ether, dried and 
weighted. Table I indicates yield and M.P. 
of various corresponding esters synthesized 
Spectral data for various synthesized 
compounds  
Methyl 2-(4-(3-fluorobenzylideneamino) 
phenyl) benzo [d] thiazole-6-carboxylate 
(5a): IR (neat) cm-1: 1742(C=O), 1630(C=N), 
1714(C=C); 1HNMR (CDCl3): δ 3.9 (s, 3H, -
CH3), δ 6.9-8.7 (m, 12H, aromatic); 13CNMR 
δ 55.06, 119.7, 120.0, 120.1, 124.2, 127.6, 
127.7, 130.3,  131.4, 134.0, 136.4, 141.1 , 141.7, 
141.8, 157.2, 164.1, 165.4, 168, 169.8. HR-
ESIMS: Calculated for C22H15FN2O2S 
(390.43010): found 390.42020. 
 
Padmavathi et al. /Research in Pharmacy 1(2) : 6-12, 2011 
 
9 
 
O
OS
N
NR
R'= -CH3, -CH2CH3, -CH2C6H5 etc
Sr No. -RCode % Yield M.P.
1 m-F
Physical nature
light yellow crystals 72
2 light Yellow crystals 75
3 Light yellow crystals 76
4 yellow crystals 71
5 yellow crystals 72
6 75
7 colourless crystals 74
Table I
270-272
280-282
290-292
261-264
228-231
272-274
246-248
O
OHS
N
NR R'-OH
SOCl2
R'
-R'
-CH2C6H5
-C2H5
-CH3
p-NO2 -CH3
-C2H5
-CH2C6H5
colourless crystals
-C2H5
8
yellow crystals
76 249-251-CH2C6H5
R= -F,-NO2, -OCH3,
P5a
P5b
P5c
P5d
P5e
P5f
P5g
P5h
p-OCH3
m-F
m-F
p-NO2
p-NO2
p-OCH3
 
 
Ethyl-2-(4-(3-fluorobenzylideneamino) 
phenyl) benzo[d] thiazole-6-carboxylate 
(5b):IR (neat) cm-1: 1746(C=O), 1634(C=N), 
1710(C=C) HNMR (CDCl3): δ 1.37-1.40 (t, 
3H, -CH3, J=5.6), δ 4.3-4.36 (q, 2H, -CH2, 
J=5.5), δ 7.0-9.0 (m, 12H, aromatic; 13CNMR 
δ 14.8, 61.4, 116.9, 117.1, 118.1, 118.9, 121.4, 
124.7, 124.8, 127.9, 127.7, 128.5, 129.9, 130.0,  
130.1, 133.5, 138.4, 139.0, 154.3, 161.2, 162.5, 
165.1, 166.7. HR-ESIMS: Calculated for 
C23H17FN2O2S (404.45668): found 404.44433.  
 
Benzyl 2-(4-(3-fluorobenzylideneamino) 
phenyl)benzo[d]thiazole-6-carboxylate 
(5c):IR (neat) cm-1: 1736(C=O), 1710(C=C), 
1622(C=N); 1HNMR (CDCl3): δ 5.4 (s, 2H, -
CH2), δ 7.0-8.8 (m, 17H, aromatic); 13CNMR 
δ 66.8, 117.9, 118.5, 118.7, 121.3, 124.6, 127.8, 
128.1, 128.3, 130.0, 133.4, 137.0, 138.2, 138.7, 
154.1, 161.4, 162.4, 165.0, 166.9. HR-ESIMS: 
Calculated for C28H19FN2O2S (466.52606): 
found 466.51334. 
 
Methyl 2-(4-(4-nitrobenzylideneamino) 
phenyl)benzo[d]thiazole-6-carboxylate 
(5d):IR (neat) cm-1: 1754(C=O), 1710(C=C), 
1622(C=N); 1HNMR (CDCl3): δ 3.9 (s, 3H, -
CH3), δ 7.4-8.8 (m, 12H, aromatic); 13CNMR 
δ 124.6, 128.7, 132.0, 132.2, 134.7, 135.9, 
138.5, 138.9, 140.9, 145.9, 147.4, 159.2, 161.7, 
168.6, 169.8, 170.5, 174.3, 187.5. HR-ESIMS: 
Calculated for C22H15N3O4S (417.43720): 
found 417.42620. 
 
Ethyl 2-(4-(4-nitrobenzylideneamino) 
phenyl)benzo[d]thiazole-6-carboxylate 
(5e):IR (neat) cm-1: 1742(C=O), 1710(C=C), 
1620(C=N); 1HNMR (CDCl3): δ 1.36-1.39 (t, 
3H, -CH3, J=5.7), δ 4.31-4.35 (q, 2H, -CH2, 
J=5.6), δ 7.4-8.8 (m, 12H, aromatic); 13CNMR 
δ 14.4, 61.1, 117.8, 121.1, 124.4, 124.4, 127.6, 
128.2, 129.8, 129.8, 131.3, 133.8, 139.8, 151.5, 
154.0, 161.0, 162.2, 162.9, 166.4. HR-ESIMS: 
Calculated for C23H17N3O4S (431.46378): 
found 431.45541. 
 
Benzyl 2-(4-(4-nitrobenzylideneamino) 
phenyl)benzo[d]thiazole-6-carboxylate 
(5f):IR (neat) cm-1: 1741(C=O), 1710(C=C), 
626(C=N); 1HNMR (CDCl3): δ 5.4 (s, 2H, -
CH2), δ 7.1-8.8 (m, 17H, aromatic); 13CNMR 
δ 61.1, 117.2, 120.5, 123.8, 127.0, 127.4, 127.5, 
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127.6, 129.2, 130.7, 1323.6, 136.3, 137.5, 139.2, 
150.9, 153.4, 160.4, 161.6, 162.2, 166.1. HR-
ESIMS: Calculated for C28H19N3O4S 
(493.53316): found 493.52206. 
 
Ethyl 2-(4-(4-methoxy benzylidene amino) 
phenyl) benzo[d] thiazole-6-carboxylate 
(5g): IR (neat) cm-1: 1745(C=O), 1623(C=N), 
1710(C=C); 1HNMR (CDCl3): δ 1.37-1.40 (t, 
3H, -CH3, J=5.6), δ 3.8 (s, 3H, -OCH3), δ 
4.32-4.36 (q, 2H, -CH2, J=5.5), δ 6.9-8.9 (m, 
12H, aromatic); 13CNMR δ 13.5, 54.9, 60.1, 
113.8, 116.8, 120.2, 123.5, 126.7, 127.2, 127.3, 
128.9, 131.2, 132.1, 137.1, 153.0, 160.0, 161.3, 
161.9, 162.9, 165.5. HR-ESIMS: Calculated 
for C24H20N2O3S (416.49220): found 
416.48210. 
 
Benzyl 2-(4-(4-methoxybenzylideneamino) 
phenyl)benzo[d] thiazole-6-carboxylate 
(P5h): IR (neat) cm-1: 1741(C=O), 
1622(C=N), 1710(C=C) 1HNMR (CDCl3): δ 
3.80 (s, 3H, -OCH3,), δ 5.4 (s, 2H, -CH2), δ 
6.8-8.9 (m, 17H, aromatic).13CNMR δ 40.5, 
51.3, 98.9, 102.4, 105.8, 109.1, 112.3, 112.6, 
112.8, 112.9, 114.5, 116.8, 117.9, 121.5, 122.7, 
145.6, 146.9, 147.5, 148.5, 151.4. HR-ESIMS: 
Calculated for C29H22N2O3S (478.56158): 
found 478.55238. 
 
Biological evaluation 
In vitro antimicrobial study 
Benzothiazoles show a wide 
spectrum of chemotherapeutic activity and a 
considerable amount of work has been done 
on the synthesis of new potent antibacterial 
and antifungal benzothiazoles. 
Synthesized compounds were 
screened for their in-vitro antibacterial 
activity against P.aeruginosa, E.coli, S.aureus, 
B.subtilis at 100 µg/ml and in-vitro 
antifungal activity against Candida albicans 
and Aspergillus Niger activities at 100 µg/ml 
concentration. Standard antibacterial 
ampicillin and standard antifungal 
ketoconazole were also screened under 
similar conditions for comparison. DMSO 
was used as a solvent control. The culture 
media was nutrient agar and method 
employed was cup plate method 
(Cruichshank, 1975). All the compounds 
showed varying degree of antibacterial 
activity. All the compounds were far less 
active than the standard drug taken.  
 
Results and discussion 
 Amongst the synthesized compounds 
several compounds exhibit antifungal and 
anti-bacterial activity. Compounds P5d, P5e, 
P5f, P5g have shown significant 
antibacterial activity Compound P5e& P5f 
was most significant We were pleased to 
observe significant activity of compound 
P5e, P5f &P5g against Candida albicans and 
Aspergillus niger. While other compound 
shown less significant activity against 
bacteria and fungi. The antimicrobial 
activity and antifungal activity studies have 
shown in table II and table III respectively.
 
Table II: Results of anti-bacterial activity 
Sl.No code Diameter of zone of inhibition ( in mm) 
  P.aeruginos
a 
E.coli S.aureus B.subtilis 
01 P5a 15 13 14 16 
02 P5b 10 10 13 12 
03 P5c 12 10 12 13 
04 P5d 16 16 15 16 
05 P5e 18 16 17 16 
06 P5f 17 16 18 16 
07 P5g 16 15 16 16 
08 P5h 15 12 11 14 
09 Ampicillin 21 20 22 20 
10 DMSO - - - - 
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Table III: Results of Anti-Fungal Activity  
 
Conclusion 
Various benzothiazole derivatives 
having 4-(benzylideneamino) phenyl 
substituents at position 2 and different 
carboxylate substituents at position 6 were 
synthesized with a view of enhancing the 
biological activity. The structure of newly 
synthesized compounds was confirmed by 
IR, 1H NMR, Mass spectra. Further 
evaluation of antimicrobial activity was 
carried out. The synthesis of various 2-(4-
(benzylideneamino) phenyl) benzothiazole-
6-carboxylate derivatives by the described 
method resulted in products with good 
yield. Micro b2iological evaluation of the 
synthesized compounds showed good to 
moderate activity.  
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